ALEMBIC
Back to Income Statement
|
ALEMBIC Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹311 Cr | ₹269 Cr | ₹191 Cr | ₹222 Cr | ₹343 Cr |
What is the latest Consolidated Net Profit of ALEMBIC ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹311 Cr |
| Mar2024 | ₹269 Cr |
| Mar2023 | ₹191 Cr |
| Mar2022 | ₹222 Cr |
| Mar2021 | ₹343 Cr |
How is Consolidated Net Profit of ALEMBIC Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹311 Cr | 15.66 | |
| Mar2024 | ₹269 Cr | 40.90 | |
| Mar2023 | ₹191 Cr | -14.14 | |
| Mar2022 | ₹222 Cr | -35.23 | |
| Mar2021 | ₹343 Cr | - | |
Compare Consolidated Net Profit of peers of ALEMBIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC | ₹1,931.1 Cr | -5.3% | -19.1% | -12.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,407.0 Cr | -2.2% | 2.5% | 1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,596.0 Cr | -1.2% | -4.5% | 5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,619.0 Cr | -2.1% | -0.2% | 36.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | -2.4% | -2.1% | 11.5% | Stock Analytics | |
| CIPLA | ₹98,767.6 Cr | -4.6% | -8% | -16.8% | Stock Analytics | |
ALEMBIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC | -5.3% |
-19.1% |
-12.9% |
| SENSEX | -3.7% |
-13.2% |
-2% |
You may also like the below Video Courses